Cesar A Arias Selected Research

Ceftaroline

1/2020	Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model.
1/2018	Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.
1/2017	Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
1/2017	Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cesar A Arias Research Topics

Disease

59	Infections 06/2024 - 06/2007
16	Endocarditis 02/2024 - 11/2007
15	Bacteremia 01/2024 - 09/2011
12	Sepsis (Septicemia) 02/2024 - 04/2014
6	Body Weight (Weight, Body) 01/2023 - 06/2012
6	Cross Infection (Nosocomial Infection) 01/2022 - 01/2019
5	COVID-19 01/2023 - 06/2020
5	Peritonitis 01/2021 - 09/2007
3	Neoplasms (Cancer) 01/2023 - 02/2017
2	Diabetes Mellitus 01/2023 - 08/2022
2	Urinary Tract Infections (Urinary Tract Infection) 01/2023 - 08/2015
2	Hypertension (High Blood Pressure) 01/2023 - 08/2022
2	Respiratory Sounds (Crackle) 01/2022 - 01/2020
2	Critical Illness (Critically Ill) 01/2020 - 09/2015
2	Osteomyelitis 01/2020 - 06/2012
2	Leukemia 01/2018 - 01/2017
1	Virus Diseases (Viral Diseases) 06/2024
1	Pneumonia (Pneumonitis) 10/2023
1	Gram-Positive Bacterial Infections 10/2023
1	Bacterial Pneumonia 02/2023
1	autosomal recessive Candidiasis familial chronic mucocutaneous 11/2022
1	Mycoses (Diseases, Fungus) 11/2022
1	Phaeohyphomycosis 11/2022
1	Neutropenia 03/2022
1	Diarrhea 01/2022
1	Clostridium Infections 01/2022
1	Communicable Diseases (Infectious Diseases) 06/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Coinfection 01/2020
1	Paresthesia (Dysesthesia) 01/2020
1	Ventilator-Associated Pneumonia 10/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Whooping Cough (Pertussis) 01/2019
1	Exanthema (Rash) 09/2018
1	Gastrointestinal Hemorrhage (Hematochezia) 09/2018
1	Vasculitis (Vasculitides) 09/2018
1	Abdominal Pain (Pain, Abdominal) 09/2018

Drug/Important Bio-Agent (IBA)

28	Daptomycin FDA Link 01/2024 - 11/2007
25	Anti-Bacterial Agents (Antibiotics)IBA 06/2024 - 06/2007
24	Vancomycin FDA LinkGeneric 01/2024 - 11/2007
9	Carbapenems (Carbapenem Antibiotics)IBA 01/2023 - 01/2017
9	Methicillin (Metin)FDA Link 01/2022 - 09/2013
8	Ampicillin (Omnipen)FDA LinkGeneric 02/2024 - 11/2007
8	Cefazolin (Ancef)FDA LinkGeneric 01/2022 - 09/2013
6	Linezolid (Zyvox)FDA Link 01/2019 - 06/2007
5	LactamsIBA 02/2024 - 01/2017
4	Anti-Infective Agents (Microbicides)IBA 10/2023 - 11/2013
4	carbapenemaseIBA 01/2023 - 01/2020
4	Ceftaroline FDA Link 01/2020 - 01/2017
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020 - 01/2017
3	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 02/2024 - 01/2019
3	AminoglycosidesIBA 01/2023 - 04/2012
3	Adenosine Monophosphate (AMP)IBA 08/2022 - 01/2018
3	tedizolidIBA 01/2020 - 01/2018
2	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023 - 06/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 08/2022
2	Penicillins (Penicillin)FDA Link 01/2022 - 01/2020
2	Nucleic AcidsIBA 01/2021 - 06/2020
2	AntibodiesIBA 09/2020 - 01/2019
2	Ertapenem (Invanz)FDA Link 01/2020 - 01/2018
2	tazobactam drug combination ceftolozaneIBA 10/2019 - 01/2017
2	LipopeptidesIBA 01/2019 - 12/2018
2	Nafcillin FDA LinkGeneric 06/2018 - 09/2013
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2017 - 11/2007
1	Proteins (Proteins, Gene)FDA Link 06/2024
1	dalbavancinIBA 10/2023
1	Capsules (Microcapsules)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	remdesivirIBA 01/2023
1	GlucansIBA 11/2022
1	dectin 1IBA 11/2022
1	methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo(d)imidazole-5-carboxylateIBA 08/2022
1	ceftolozaneIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 12/2021
1	AntigensIBA 06/2021
1	Meropenem (Merrem)FDA LinkGeneric 01/2021
1	omadacyclineIBA 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	ceftazidime drug combination avibactamIBA 01/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2020
1	CefiderocolIBA 01/2020
1	Aztreonam FDA LinkGeneric 01/2020
1	Pertussis VaccineIBA 01/2019
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 09/2018

Therapy/Procedure

25	Therapeutics 02/2024 - 10/2008
2	Mechanical Ventilators (Ventilator) 02/2023 - 10/2019
2	Fecal Microbiota Transplantation 01/2023 - 05/2019
1	Organ Transplantation 02/2024
1	Phage Therapy 01/2023
1	Salvage Therapy 01/2023
1	Transplantation 11/2022
1	Urinary Catheters 03/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Remission Induction 01/2021
1	Precision Medicine 01/2020
1	Catheters 06/2018
1	Length of Stay 01/2018